Henry Schein Inc (HSIC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Henry Schein Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 85.80 $ — 91% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 1.4% failed
- More than 10% revenue growth is expected for the coming year 3.8% failed
- Share count grows by less than 3% a year -4.0% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 8.4% failed
- Gross margin at 40% or higher and without meaningful erosion 29.1% failed
- Goodwill from acquisitions does not grow faster than revenue 37.6% failed
- Net debt below twice EBITDA 3.5 x EBITDA failed
- Operating cash flow covers the profits of the last three years 856 m passed
- Return on capital at 15% or higher, or up versus two years ago 9.5% passed
- Insiders hold at least 10% or are net buyers 0.8% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 4.1% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 16
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5.34 | 5.25 – 5.45 | 13,745 | 7.5% | 17 |
| 12/31/2027 | 5.91 | 5.74 – 6.19 | 14,254 | 10.5% | 17 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 1.22 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.75 | 443.50 | 3,191 | 5.80 | 2.90 | 204 | 159 |
| 2025: Q1 | 0.88 | 22.90 | 3,168 | -0.10 | 3.50 | 37 | -6 |
| 2025: Q2 | 0.70 | -13.30 | 3,240 | 3.30 | 2.70 | 120 | 88 |
| 2025: Q3 | 0.83 | 7.10 | 3,339 | 5.20 | 3.00 | 174 | 141 |
| 2025: Q4 | 0.85 | 14.10 | 3,437 | 7.70 | 2.90 | 381 | 338 |
| 2026: Q1 | 0.92 | 4.60 | 3,368 | 6.30 | 3.20 | -97 | -136 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 11,572 | 817 | 507 | 3.12 | 615 | 2,793 | 6,760 |
| 2017 | 12,462 | 865 | 406 | 2.57 | 546 | 2,812 | 7,864 |
| 2018 | 13,202 | 693 | 536 | 3.49 | 685 | 2,961 | 8,501 |
| 2019 | 9,986 | 733 | 508 | 3.40 | 654 | 2,998 | 7,151 |
| 2020 | 10,119 | 567 | 402 | 2.80 | 599 | 3,348 | 7,773 |
| 2021 | 12,401 | 855 | 624 | 4.40 | 710 | 3,425 | 8,481 |
| 2022 | 12,647 | 938 | 538 | 3.91 | 602 | 3,446 | 8,607 |
| 2023 | 12,339 | 714 | 416 | 3.16 | 500 | 3,655 | 10,573 |
| 2024 | 12,673 | 729 | 390 | 3.05 | 848 | 3,393 | 10,218 |
| 2025 | 13,184 | 758 | 398 | 3.27 | 712 | 3,245 | 11,215 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Henry Schein, Inc. bietet weltweit Gesundheitsprodukte und -dienste für niedergelassene Zahn- und Allgemeinmediziner an.
| Employees | 25,000 |
|---|---|
| Headquarters | Melville, NY |
| Address | 135 Duryea Road, 11747 Melville, United States |
| Phone | 631 843 5500 |
| Website | henryschein.com |
| IPO Date | 3. Nov 1995 |
| ISIN | US8064071025 |
| Stock Split | 1275:1000 on 02/08/2019 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Ronald N. South | Senior VP & CFO | 1962 |
| Michael Saul Ettinger | Executive VP & COO | 1961 |
| Mark E. Mlotek | Executive VP & Chief Strategic Officer | 1956 |
| Andrea Albertini | Chief Executive Officer of Global Distribution & Technology | 1970 |
| Frederick M. Lowery | CEO & Director | 1971 |
| Olga Timoshkina | VP of Corporate Finance & Chief Accounting Officer | – |
| Christopher Pendergast | Senior VP & CTO | 1963 |
| Graham Stanley | VP of Investor Relations & Strategic Finance Project Officer | – |
| Kelly Murphy J.D. | Senior VP & General Counsel | 1981 |
| Christine Sheehy | Senior VP & Chief Human Resources Officer | 1968 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.